Methylphenidate Hydrochloride (LA)
These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955
e5db854a-1c77-4faf-9e60-daf9c9b6cfa0
HUMAN PRESCRIPTION DRUG LABEL
Feb 23, 2023
Mayne Pharma
DUNS: 867220261
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Methylphenidate Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (18)
Methylphenidate Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (18)
Methylphenidate Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (18)
Methylphenidate Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (18)
Methylphenidate Hydrochloride
Product Details
FDA regulatory identification and product classification information